Inovio Pharmaceuticals to Report First Quarter 2018 Financial Results on May 9, 2018

    NEXT STORY
    Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009
    PREV STORY
    Exalenz Bioscience Appoints Roy Golan as President and Chief Financial Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer

    NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ...

    author_avatar
    NASDAQ Market News

    Edge’s EG-1962 Phase 3 NEWTON 2 Study Continues as Planned Following Completion of Futility Analysis

    BERKELEY HEIGHTS, N.J., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a ...

    author_avatar
    NASDAQ Market News

    Turning Point Therapeutics Initiates Phase 1 Clinical Study of Tpx-0022, a Novel Met Inhibitor Targeting Advanced Solid Tumors

    author_avatar
    NASDAQ Market News